Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma

Figure 1

Levels of autoantibodies against STIP1 in ESCC. (a) Scatter plots of OD values of autoantibodies against STIP1 from sera of normal controls, ESCC patients, and early-stage ESCC patients in the training cohort. Black horizontal lines are means and error bars are SEs. (b) Median levels and interquartile ranges of serum autoantibodies against STIP1 in normal controls, ESCC patients, and early-stage ESCC patients in the training cohort are, respectively, illustrated by box plot, and the whiskers show minimum and maximum value. (c) Scatter plots of OD values of autoantibodies against STIP1 from sera of normal controls, ESCC patients, and early-stage ESCC patients in the validation cohort. Black horizontal lines are means and error bars are SEs. (d) Median levels and interquartile ranges of serum autoantibodies against STIP1 in normal controls, ESCC patients, and early-stage ESCC patients in the validation cohort are, respectively, illustrated by box plot, and the whiskers show minimum and maximum value.

(a)

(b)

(c)

(d)